Ishikawa Takashi

イシカワタカシ | Ishikawa Takashi

Affiliation and department：
Other affiliations (1)：

横浜市立大学客員教授

Homepage URL (1)： http://tokyo-med-breast.jp

Research field (1)： General surgery, pediatric surgery

Research keywords (2)：乳腺外科学 , 乳癌

Research theme for competitive and other funds (2)：

2017 - 乳腺悪性腫瘍患者血小板mRNAの診断的価値についての検討
2017 - マイトファジーにおけるBRCA1の機能解明とBRCA1変異乳癌の新規治療開発

Papers (32)：

Asaoka M, Narui K, Suganuma N, Chishima T, Yamada A, Sugae S, Kawai S, Uenaka N, Teraoka S, Miyahara K, et al. Clinical and pathological predictors of recurrence in breast cancer patients achieving pathological complete response to neoadjuvant chemotherapy. Europian Journal of Surgical Oncology. 2019. 45. 12. 2289-2294
Asaoka M, Ishikawa T, Takabe K, Patnaik SK. APOBEC3-Mediated RNA Editing in Breast Cancer is Associated with Heightened Immune Activity and Improved Survival. International Journal of Molecular Sciences. 2019. 20. 22
Narui K, Ishikawa T, Shimizu D, Yamada A, Tanabe M, Sasaki T, Oba MS, Morita S, Nawata S, Kida K, et al. Anthracycline could be essential for triple-negative breast cancer: A randomised phase II study by the Kanagawa Breast Oncology Group (KBOG) 1101. Breast. 2019. 47. 1-9
Ueda A, Oikawa K, Fujita K, Ishikawa A, Sato E, Ishikawa T, Kuroda M, Kanekura K. Therapeutic potential of PLK1 inhibition in triple-negative breast cancer. Lab Invest. 2019. 99. 9. 1275-1286
Satake T, Muto M, Kou S, Yasumura K, Ishikawa T, Maegawa J. Contralateral unaffected breast augmentation using zone IV as a SIEA flap during unilateral DIEP flap breast reconstruction. J Plast Reconstr Aesthet Surg. 2019. 72. 9. 1537-1547

ｍore...

Books (10)：

日本臨床特集ー診断・治療の最新知見ー 76巻5号
(株)日本臨牀社 2018
Bone and Calcium metabolism associated with malignancy. Vol.28 No.11
2018
乳がん薬物療法副作用マネジメントプロのコツ
(株)メジカルビュー社 2017
臨床雑誌『外科』第79巻第5号
南江堂 2017
乳癌学-最新の診断と治療- 第75巻増刊号3
2017

ｍore...

Lectures and oral presentations (14)：

Prospective Cohort Study of Febrile Neutropenia in Breast Cancer Patients with Neoadjuvant and Adjuvant Chemotherapy: CSPOR=BC FN Study
(2019 San Antonio Breast Cancer Symposium 2019)
Management of Febrile Neutropenia in Breast Cancer Patients with Neoadjuvant and Adjuvant Chemotherapy.
(2019 Taipei International Breast Cancer Symposium (TIBCS) 2019)
Chemotherapy as Partner of Immunotherapy for Advanced Her2 Negative Breast Cancer
(2019 Taipei International Breast Cancer Symposium (TIBCS) 2019)
Indication of Nipple Sparing Mastectomy and Reconstruction in Young Breast Cancer Patients.
(Taiwan Oncoplastic Breast Surgery Society 2018 Annual Meeting 2018)
High APOBEC3C-H gene expression in tumor associates with better survival in breast cancer
(2018 San Antonio Breast Cancer Symposium 2018)

ｍore...

Education (2)：

1987 - 1991 Yokohama City University
1981 - 1987 Yokohama City University

Professional career (1)：

博士(医学) (横浜市立大学)

Work history (4)：

2014/04 - 現在 TOKYO MEDICAL UNIVERSITY Department of Breast Oncology and Surgery Professor & Chairman
2007/04 - 2014/03 横浜市立大学医学部乳腺甲状腺外科部長、准教授
2003/04 - 2007/03 横浜市立大学付属市民総合医療センター総合外科講師
1990/10 - 1992/09 米国カリフォルニア州立大学アーバイン校研究員

Committee career (7)：

2018/09 - 現在一般社団法人日本乳房オンコプラスティックサージャリー学会理事
2016/06 - 現在日本乳癌学会理事
2012/10 - 現在日本外科病理学会評議員
2012/08 - 現在一般社団法人日本乳房オンコプラスティックサージャリー学会評議員
2006/05 - 現在日本乳癌学会評議員

Show all

Awards (1)：

2008/04 - 横浜市立大学横浜市立大学医学会賞

Association Membership(s) (11)：

AACR , ASCO , 日本臨床腫瘍学会 , JAPAN SOCIETY OF CLINICAL ONCOLOGY , 日本外科病理学会 , THE JAPANESE SOCIETY OF GASTROENTEROLOGICAL SURGERY , 日本乳房オンコプラスティックサージャリー学会 , 日本乳癌検診学会 , THE JAPANESE CANCER ASSOCIATION , 日本乳癌学会 , JAPAN SURGICAL SOCIETY

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page